Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MOM Biotech, operating through the MOM Research and Innovation Center, is a biotechnology company dedicated to the 'Management of Microbes' with a primary focus on maternal and infant health. The company leverages microbiome science to develop targeted interventions, including probiotics and prebiotics, aimed at addressing global health challenges such as childhood stunting and malnutrition. By analyzing the maternal-infant microbial axis, MOM Biotech creates evidence-based solutions to optimize gut health and developmental outcomes. Their research integrates advanced genomic sequencing and clinical validation to provide precision microbiome therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MOM Research and Innovation Center.